4//SEC Filing
Costa Carlos 4
Accession 0001562180-24-006927
CIK 0001822462other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 4:01 PM ET
Size
14.4 KB
Accession
0001562180-24-006927
Insider Transaction Report
Form 4
Costa Carlos
Chief People Officer
Transactions
- Sale
Common Stock
2024-09-23$10.17/sh−857$8,716→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2024-09-20−35,756→ 40,646 totalExercise: $3.72Exp: 2029-02-12→ Common Stock (35,756 underlying) - Exercise/Conversion
Common Stock
2024-09-23$3.72/sh+857$3,188→ 857 total - Exercise/Conversion
Common Stock
2024-09-20$3.72/sh+35,756$133,012→ 35,756 total - Exercise/Conversion
Stock Option (right to buy)
2024-09-23−857→ 39,789 totalExercise: $3.72Exp: 2029-02-12→ Common Stock (857 underlying) - Sale
Common Stock
2024-09-20$10.04/sh−35,756$358,990→ 0 total
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.22 per share.
- [F3]The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001939167
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 4:01 PM ET
- Size
- 14.4 KB